Does aristada cause restlessness?

Can Aristada cause restlessness?
Aristada (aripiprazole lauroxil) can produce akathisia, a form of restlessness marked by an inner urge to move. Clinical trials listed akathisia among the most common side effects, occurring in roughly 11 percent of patients receiving the 441 mg dose.

How common is akathisia with Aristada?
Rates vary with dose. The 441 mg injection showed akathisia in about 11 percent of participants, while the 882 mg dose reached 12 percent. These figures come from placebo-controlled studies submitted to the FDA.

Why does Aristada trigger restlessness?
Aripiprazole partially blocks dopamine D2 receptors in the brain. When this blockade occurs in motor pathways, it can create the subjective feeling of restlessness that defines akathisia. The effect is dose-related and tends to appear within the first few weeks of treatment.

What should patients do if restlessness develops?
Tell the prescriber promptly. Mild cases may improve with dose reduction, a switch to a different antipsychotic, or short-term use of a beta-blocker such as propranolol. Severe or persistent akathisia may require stopping Aristada.

How does Aristada compare with oral aripiprazole on restlessness?
Both formulations carry the same akathisia risk because they deliver the same active molecule. Long-acting Aristada simply releases the drug more slowly, which can make side-effect timing less predictable rather than less intense.

When does the restlessness usually start and fade?
Most reports occur in the first 4–6 weeks. For many patients the symptom lessens over several weeks as the body adjusts; others need active management. Because Aristada stays in the system for weeks after each injection, any adjustment takes longer to show results than with daily tablets.

Are there other movement-related side effects to watch for?
In addition to akathisia, Aristada labels list tremor, muscle stiffness, and, rarely, tardive dyskinesia. Patients or caregivers should report any new involuntary movements to the clinician.

Where can prescribers and patients find the latest safety data?
Full prescribing information, including akathisia rates by dose, is available on the FDA label and on DrugPatentWatch.com.